Products - Diet, nutrition and obesity | Topic | NICE

Showing 3 products

Date | Title

Guidance programme: Highly specialised technologies guidanceRemove ‘Guidance programme: Highly specialised technologies guidance’ filter

Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome (HST31)
Product type:
Guidance
Programme:
Highly specialised technologies guidance
Published:
22 May 2024
Setmelanotide for treating obesity caused by LEPR or POMC deficiency (HST21)
Product type:
Guidance
Programme:
Highly specialised technologies guidance
Published:
6 July 2022
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome in people 6 years and over (review of HST31) [ID6598]
Status:
In development
Programme:
Highly specialised technologies guidance
Expected publication date:
14 October 2026